ClinVar Genomic variation as it relates to human health
NM_006765.4(TUSC3):c.992C>A (p.Ser331Ter)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_006765.4(TUSC3):c.992C>A (p.Ser331Ter)
Variation ID: 95432 Accession: VCV000095432.45
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 8p22 8: 15748429 (GRCh38) [ NCBI UCSC ] 8: 15605938 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Jun 29, 2015 Oct 20, 2024 Nov 24, 2023 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_006765.4:c.992C>A MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_006756.2:p.Ser331Ter nonsense NM_001356429.2:c.992C>A NP_001343358.1:p.Ser331Ter nonsense NM_178234.2:c.992C>A NP_839952.1:p.Ser331Ter nonsense NC_000008.11:g.15748429C>A NC_000008.10:g.15605938C>A NG_012141.2:g.213209C>A - Protein change
- S331*
- Other names
- -
- Canonical SPDI
- NC_000008.11:15748428:C:A
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
-
functionally_abnormal; Sequence Ontology [ SO:0002218]
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
-
Trans-Omics for Precision Medicine (TOPMed) 0.00002
The Genome Aggregation Database (gnomAD) 0.00007
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
TUSC3 | - | - |
GRCh38 GRCh37 |
277 | 369 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Pathogenic/Likely pathogenic (2) |
criteria provided, multiple submitters, no conflicts
|
Aug 1, 2020 | RCV000081456.30 | |
Pathogenic (5) |
criteria provided, multiple submitters, no conflicts
|
Nov 24, 2023 | RCV001039775.12 | |
Pathogenic (1) |
criteria provided, single submitter
|
Nov 18, 2019 | RCV001171632.3 | |
Pathogenic (1) |
criteria provided, single submitter
|
Jun 21, 2023 | RCV003338410.2 | |
Pathogenic (1) |
criteria provided, single submitter
|
Nov 1, 2023 | RCV003388826.1 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Pathogenic
(Sep 09, 2012)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: unknown
Allele origin:
germline
|
Eurofins Ntd Llc (ga)
Accession: SCV000113387.8
First in ClinVar: Jan 17, 2014 Last updated: Jun 29, 2015 |
Number of individuals with the variant: 4
Sex: mixed
|
|
Pathogenic
(Jun 03, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Intellectual disability, autosomal recessive 7
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV001203321.4
First in ClinVar: Apr 15, 2020 Last updated: Feb 14, 2024 |
Comment:
For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 95432). This premature translational stop signal … (more)
For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 95432). This premature translational stop signal has been observed in individual(s) with intellectual disability and autism (PMID: 23806237). This variant is present in population databases (rs200667343, gnomAD 0.03%). This sequence change creates a premature translational stop signal (p.Ser331*) in the TUSC3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TUSC3 are known to be pathogenic (PMID: 18455129, 25626710). (less)
|
|
Pathogenic
(Jun 21, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Inborn genetic diseases
Affected status: unknown
Allele origin:
germline
|
Ambry Genetics
Accession: SCV004066175.2
First in ClinVar: Oct 28, 2023 Last updated: May 01, 2024 |
Comment:
The c.992C>A (p.S331*) alteration, located in exon 9 (coding exon 9) of the TUSC3 gene, consists of a C to A substitution at nucleotide position … (more)
The c.992C>A (p.S331*) alteration, located in exon 9 (coding exon 9) of the TUSC3 gene, consists of a C to A substitution at nucleotide position 992. This changes the amino acid from a serine (S) to a stop codon at amino acid position 331. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. Based on data from gnomAD, the A allele has an overall frequency of 0.009% (25/282626) total alleles studied. The highest observed frequency was 0.032% (8/25094) of European (Finnish) alleles. This variant was identified in the homozygous state in an individual with intellectual disability (ID), attention deficit hyperactivity disorder, microcephaly, hypotonia, and skeletal abnormalities (Sabo, 2020). It was also identified in the compound heterozygous state with a whole gene deletion in an individual with ID and autism (Jones, 2013). Based on the available evidence, this alteration is classified as pathogenic. (less)
|
|
Pathogenic
(Nov 18, 2019)
|
criteria provided, single submitter
Method: research
|
Intellectual disability
(Autosomal recessive inheritance)
Affected status: yes
Allele origin:
inherited
|
Human Genome Sequencing Center Clinical Lab, Baylor College of Medicine
Accession: SCV000999932.1
First in ClinVar: Jun 08, 2020 Last updated: Jun 08, 2020 |
Comment:
The c.992C>A (p.Ser331Ter) variant in TUSC3 gene is predicted to introduce a premature translation termination codon. It is predicted to cause loss of normal protein … (more)
The c.992C>A (p.Ser331Ter) variant in TUSC3 gene is predicted to introduce a premature translation termination codon. It is predicted to cause loss of normal protein function either through abnormal, prematurely truncated protein, or by absence of protein product due to nonsense-mediated mRNA decay. This variant has been observed at an ultra-low frequency in the general population (gnomAD database 25/282,626). This variant has been reported previously in the hemizygous state in an individual with intellectual disability and autism where it was in trans with a TUSC3 gene deletion (PMID 23806237). Biallelic loss-of-function variants in TUSC3 gene have been reported to cause autosomal recessive intellectual disability in multiple studies (PMID: 27148795, 18452889, 18455129). This variant was identified in an adult undergoing exome sequencing due to a history of intellectual disability and developmental delay. For these reasons, this variant has been classified as Pathogenic. (less)
Age: 30-39 years
Sex: male
|
|
Pathogenic
(-)
|
criteria provided, single submitter
Method: clinical testing
|
Intellectual disability, autosomal recessive 7
(Autosomal recessive inheritance)
Affected status: yes
Allele origin:
germline
|
Institute for Medical Genetics and Human Genetics, Charité - Universitätsmedizin Berlin
Accession: SCV001364062.1
First in ClinVar: Jul 30, 2020 Last updated: Jul 30, 2020 |
Comment:
In the patient the TUSC3 gene contained the two variants c.992C>A and c.420dup in the compound heterozygous state. The variant c.992C>A leads to a premature … (more)
In the patient the TUSC3 gene contained the two variants c.992C>A and c.420dup in the compound heterozygous state. The variant c.992C>A leads to a premature stop codon, which probably causes a premature termination of protein biosynthesis at amino acid position 331. This variant is also detectable in the patient's father and is therefore paternally inherited. TUSC3 (OMIM #601385) encodes a protein involved in N-glycosylation and the magnesium transport system of the plasma membrane (PMID: 18452889, 19717468). Pathogenic homozygous nonsense variants in the TUSC3 gene have already been described in connection with the TUSC3-associated autosomal recessive mental retardation syndrome. Affected individuals show a non-syndromal global developmental delay and mild to severe mental retardation (MIM: 611093; PMID: 18452889, 27148795, 21739581). The paternally inherited variant c.992C>A p.(Ser331*) found in the patient is listed in the databases HGMD and ClinVar and described and published as pathogenic (HGMD: CM137875; ClinVar ID: 95432; PMID: 23806237). According to the current state of knowledge, the change presented here is a pathogenic variant (class 5). (less)
Clinical Features:
Delayed speech and language development (present) , Unsteady gait (present)
Sex: female
|
|
Pathogenic
(Nov 08, 2018)
|
criteria provided, single submitter
Method: clinical testing
|
Intellectual disability, autosomal recessive 7
Affected status: yes
Allele origin:
unknown
|
Centre for Mendelian Genomics, University Medical Centre Ljubljana
Accession: SCV001366400.2
First in ClinVar: Jul 04, 2020 Last updated: Dec 12, 2020 |
Comment:
This variant was classified as: Pathogenic. The following ACMG criteria were applied in classifying this variant: PVS1,PS1,PM2.
|
|
Pathogenic
(Nov 01, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Intellectual disability, autosomal recessive 24
(Autosomal recessive inheritance)
Affected status: yes
Allele origin:
inherited
|
Institute of Human Genetics, University of Leipzig Medical Center
Accession: SCV004100745.1
First in ClinVar: Nov 04, 2023 Last updated: Nov 04, 2023 |
Comment:
Criteria applied: PVS1,PM3_STR,PM2_SUP
Clinical Features:
Bilateral tonic-clonic seizure (present) , Focal impaired awareness clonic seizure (present) , Atypical behavior (present) , Global developmental delay (present) , Intellectual disability (present)
Sex: female
|
|
Pathogenic
(Nov 24, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Intellectual disability, autosomal recessive 7
Affected status: unknown
Allele origin:
germline
|
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Accession: SCV004223150.1
First in ClinVar: Jan 06, 2024 Last updated: Jan 06, 2024 |
Comment:
Variant summary: TUSC3 c.992C>A (p.Ser331X) results in a premature termination codon, predicted to cause a truncation of the encoded protein, although it is not expected … (more)
Variant summary: TUSC3 c.992C>A (p.Ser331X) results in a premature termination codon, predicted to cause a truncation of the encoded protein, although it is not expected to result in nonsense mediated decay. A variant downstream of this position (p.Ser343Thr) has been classified as pathogenic by ClinVar submitters with clinical evidence. The variant allele was found at a frequency of 8.4e-05 in 251246 control chromosomes (gnomAD). c.992C>A has been reported in the literature in individuals affected with Intellectual Disability (Jones_2013, Sabo_2020), and one was reported as compound heterozygous with a whole gene deletion. These data indicate that the variant is likely associated with disease. The following publications have been ascertained in the context of this evaluation (PMID: 23806237, 32767738). Seven submitters have cited clinical-significance assessments for this variant to ClinVar after 2014, and classified it as pathogenic (n=5), likely pathogenic (n=1), or uncertain significance (n=1). Based on the evidence outlined above, the variant was classified as pathogenic. (less)
|
|
Pathogenic
(Jul 17, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Intellectual disability, autosomal recessive 7
(Autosomal recessive inheritance)
Affected status: yes
Allele origin:
germline
|
Victorian Clinical Genetics Services, Murdoch Childrens Research Institute
Additional submitter:
Shariant Australia, Australian Genomics
Accession: SCV005086145.1
First in ClinVar: Jul 23, 2024 Last updated: Jul 23, 2024 |
Comment:
Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism … (more)
Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with intellectual developmental disorder, autosomal recessive 7 (MIM#611093). (I) 0106 - This gene is associated with autosomal recessive disease. (I) 0205 - Variant is predicted to result in a truncated protein (premature termination codon is NOT located at least 54 nucleotides upstream of the final exon-exon junction) with less than 1/3 of the protein sequence affected. (SP) 0251 - This variant is heterozygous. (I) 0304 - Variant is present in gnomAD (v2) <0.01 for a recessive condition (25 heterozygotes, 0 homozygotes). (SP) 0600 - Variant affects part of the annotated OST3/OST6 family, transporter family domain (DECIPHER). (I) 0710 - Another protein truncating variant comparable to the one identified in this case has inconclusive previous evidence for pathogenicity. A single downstream truncating variant has been reported as a VUS (ClinVar). Additionally, a downstream missense variant, p.(Ser343Thr), has been described twice as pathogenic, and observed in at least two affected individuals (ClinVar, PMID: 26077850, PMID: 34646667). (I) 0801 - This variant has strong previous evidence of pathogenicity in unrelated individuals. This variant has been reported multiple times as pathogenic, and described in both homozygous and compound heterozygous individuals with intellectual disability, developmental delay and/or autism (ClinVar, PMID: 32767738). (SP) 1205 - This variant has been shown to be maternally inherited (by trio analysis). (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign (less)
|
|
Likely pathogenic
(Aug 01, 2020)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: yes
Allele origin:
germline
|
CeGaT Center for Human Genetics Tuebingen
Accession: SCV001500492.23
First in ClinVar: Mar 14, 2021 Last updated: Oct 20, 2024 |
Number of individuals with the variant: 1
|
Germline Functional Evidence
Functional
Help
The functional consequence of the variant, based on experimental evidence and provided by the submitter. consequence |
Method
Help
A brief description of the method used to determine the functional consequence of the variant. A citation for the method is included, when provided by the submitter. |
Result
Help
A brief description of the result of this method for this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting functional evidence for the germline classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
---|---|---|---|---|
functionally_abnormal
|
Institute for Medical Genetics and Human Genetics, Charité - Universitätsmedizin Berlin
Accession: SCV001364062.1
|
|
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
Two Sisters From Qatar With TUSC3 Genetic Mutation: Psychiatric Considerations. | Albobali Y | Cureus | 2021 | PMID: 34646667 |
Community-based recruitment and exome sequencing indicates high diagnostic yield in adults with intellectual disability. | Sabo A | Molecular genetics & genomic medicine | 2020 | PMID: 32767738 |
High diagnostic yield of clinical exome sequencing in Middle Eastern patients with Mendelian disorders. | Yavarna T | Human genetics | 2015 | PMID: 26077850 |
Homozygous Truncating Intragenic Duplication in TUSC3 Responsible for Rare Autosomal Recessive Nonsyndromic Intellectual Disability with No Clinical or Biochemical Metabolic Markers. | El Chehadeh S | JIMD reports | 2015 | PMID: 25626710 |
Molecular diagnostic testing for congenital disorders of glycosylation (CDG): detection rate for single gene testing and next generation sequencing panel testing. | Jones MA | Molecular genetics and metabolism | 2013 | PMID: 23806237 |
Oligosaccharyltransferase-subunit mutations in nonsyndromic mental retardation. | Molinari F | American journal of human genetics | 2008 | PMID: 18455129 |
http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=TUSC3 | - | - | - | - |
Text-mined citations for rs200667343 ...
HelpRecord last updated Nov 25, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.